Emerging technologies and fourth generation issues in cartilage repair

Sports Medicine and Arthroscopy Review

Volumn 16, Issue 4, 2008, Pages 246-254

  Kessler, Michael W ^a   Ackerman, George ^a   Dines, Joshua S ^b   Grande, Daniel ^a  

^a LONG ISLAND JEWISH MEDICAL CENTER   (United States)

^b HOSPITAL FOR SPECIAL SURGERY   (United States)

Author keywords

Biomaterials; Cartilage repair; Chondrocyte; Gene therapy; Growth factors; Stem cells; Tissue engineering

Indexed keywords

ARGININE; ASPARTIC ACID; BIOMATERIAL; BONE MORPHOGENETIC PROTEIN 9; DEXAMETHASONE; ELASTIN; GLYCINE; GROWTH FACTOR; HYALURONIC ACID; MACROGOL; OSTEOGENIC PROTEIN 1; SOMATOMEDIN C; SONIC HEDGEHOG PROTEIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

AMINO ACID SEQUENCE; AUTOGRAFT; AUTOTRANSPLANTATION; BIOMECHANICS; BIOTECHNOLOGY; BONE GRAFT; CARTILAGE; CHONDROCYTE IMPLANTATION; CHONDROPATHY; EXTRACELLULAR MATRIX; GENE THERAPY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HYALINE CARTILAGE; HYDROGEL; MESENCHYMAL STEM CELL TRANSPLANTATION; MICROFRACTURE; MOSAICPLASTY; NONVIRAL GENE DELIVERY SYSTEM; NONVIRAL GENE THERAPY; OSTEOARTHRITIS; POLYMERIZATION; PRIORITY JOURNAL; REGENERATION; REVIEW; TISSUE ENGINEERING; TISSUE REPAIR; TOTAL KNEE REPLACEMENT;

BIOCOMPATIBLE MATERIALS; BIOMECHANICS; CARTILAGE, ARTICULAR; CHONDROCYTES; FEMALE; FORECASTING; GENE THERAPY; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KNEE INJURIES; MALE; RISK ASSESSMENT; STEM CELL TRANSPLANTATION; TENSILE STRENGTH; TISSUE ENGINEERING; TISSUE SCAFFOLDS; TISSUE TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS; TREATMENT OUTCOME;

EID: 57349165998     PISSN: 10628592     EISSN: 15381951     Source Type: Journal    
DOI: 10.1097/JSA.0b013e31818d56b3     Document Type: Review

References (116)

1. Verdonk R, Steinwachs M, Vanlauwe J, et al. Trends in cartilage repair. Available at: http://www.tigenix.com/download/Trendx-in-cartilage-repair. pdf. Accessed December 20, 2007.
2. Gelber AC, Hochberg MC, Mead LA, et al. Joint injury in young adults and risk for subsequent knee and hip osteoarthritis. Ann Intern Med. 2000;133:321-328.
3. Lewis PB, McCarty LP, Kang RW, et al. Basic science and treatment options for articular cartilage injuries. J Orthop Sports Phys Ther. 2006;36:717-727.
4. Steadman JR, Rodkey WG, Briggs KK. Microfracture to treat fullthickness chondral defects: surgical technique, rehabilitation, and outcomes. J Knee Surg. 2002; 15:170-176.
5. Knutsen G. Engebretsen L, Ludvigsen TC, et al. Autologous chondrocyte implantation compared with microfracture in the knee. A randomized trial. J Bone Joint Surg Am. 2004;86-A: 455-464.
6. Brown WE, Potter HG, Marx RG, et al. Magnetic resonance imaging appearance of cartilage repair in the knee. Clin Orthop Re/at Res. 2004; 422:214-223.
7. Mithoefer K, Williams RJ III, Warren RF, et al. The microfracture technique for the treatment of articular cartilage lesions in the knee. A prospective cohort study. J Bone Joint Surg Am. 2005;87:1911-1920.
8. Kreuz PC, Steinwachs MR, Erggelet C. et al. Results after microfracture of full-thickness chondral defects in different compartments in the knee. Osteoarthritis Cartilage. 2006; 14:1119-1125.
9. Redman SN, Oldfield SF, Archer CW. Current strategies for articular cartilage repair. Eur Cells Mater. 2005;9:23-32.
10. Hangody L, Feczko P, Bartha L, et al. Mosaicplasty for the treatment of articular defects of the knee and ankle. Clin Orthop. 2001;391(suppl):S328-S336.
11. Jakob RP, Franz T, Gautier E, et al. Autologous osteochondral grafting in the knee: indication, results, and reflections. Clin Orthop. 2002;401:170-184.
12. Evans PJ, Miniaci A, Hurtig MB. Manual punch versus power harvesting of osteochondral grafts, Arthroscopy. 2004;20:306-310.
13. Brittberg M, Lindahl A, Nilsson A, et al. Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. N Engl J Med. 1994;331:889-895.
14. Brittberg M. Autologous chondrocyte transplantation. Clin Orthop. 1999;367(suppl):S147-S155.
15. Knutsen G, Drogset JO, Engebretsen L, et al. A randomized trial comparing autologous chondrocyte implantation with microfracture. Findings at five years. J Bone Joint Surg Am. 2007;89:2105-2112.
16. Bentley G, Biant LC, Carrington RW. et al. A prospective randomised comparison of autologous chondrocyte implantation versus mosaicplasty for osteochondral defects in the knee. J Bone Joint Surg Br. 2003;85:223-230.
17. Minas T. Chondrocyte implantation in the repair of chondral lesions of the knee: economics and quality of life. Am J Orthop. 1998;27:739-744.
18. Micheli LJ. Browne JE. Erggelet C. et al. Autologous chondrocyte implantation of the knee: multicenter experience and minimum 3-year follow up. Clin J Sport Med. 2001;11:223-228.
19. Peterson L. Minas T. Brittberg M. et al. Two to 9 year outcome after autologous chondrocyte transplantation of the knee. Clin Orthop. 2000;374:212-234.
20. Tuan R. Boland G. Tuli R. Adult mesenchymal stem cells and cellbased tissue engineering. Arthritis Res. 2003;5:32-45.
21. Jancar J. Slovikova A. Amler E. et al. Mechanical response of porous scaffolds for cartilage engineering. Physiol Res. 2007;56(suppl 1): S17-S25.
22. Pei M. Solchaga LA, Seidel J. et al. Bioreactors mediate the effectiveness of tissue engineering scaffolds. FASEB J. 2002;16:1691-1694.
23. Hutmacher DW. Scaffold design and fabrication technologies for engineering tissues-state of the art and future perspectives. J Biomater Sci Polym Ed. 2001;12:107-124.
24. Gu ZQ. Xiao JM. Zhang XH. The development of artificial articular cartilage-PVA-hydrogel. Biomed Mater Eng. 1998;8:75-81.
25. Nettles DL. Vail TP. Morgan MT. et al. Photocrosslinkable hyaluronan as a scaffold for articular cartilage repair. Ann Biomed Eng. 2004;32:391-397.
26. Caplan AI. Mesenchymal stem cells. J Orthop Res. 1991; 9:641-650.
27. Roufosse CA, Direkze NC, Otto WR, Wright NA. Circulating mesenchymal stem cells. Int J Biochem Cell Biol. 2004;36:585-597.
28. Barry FP. Biology and clinical applications of mesenchymal stem cells. Birth Defects Res C Embryo Today. 2003;69:250-256.
29. Majumdar MK, Thiede MA, Mosca JD, et al. Phenotypic and functional comparison of cultures of marrow-derived mesenchymal stem cells (MSCs) and stromal cells. J Cell Physiol. 1998;176:57-66.
30. Freed LE, Marquis JC, Nohria A, et al. Neocartilage formation in vitro and in vivo using cells cultured on synthetic biodegradable polymers. J Biomed Mater Res. 1993;27:11-23.
31. Hendrickson DA, Nixon AJ, Grande DA, et al. Chondrocyte-fibrin matrix transplants for resurfacing extensive articular cartilage defects. J Orthop Res. 1994;12:484-497.
32. Tuli R, Li WJ, Tuan RS. Current state of cartilage tissue engineering. Arthritis Res Ther. 2003;5:235-238.
33. Kim H. Zaffagnini S, Mizuno S. et al. A peek into the possible future of management of articular cartilage injuries: gene therapy and scaffolds for cartilage repair. J Orthop Sports Phvs Ther. 2006;36:765-773.
34. Kim TK, Park JS, Lee MC, et al. Alternative splicing of type II procollagen gene in the dedifferentiation of rat epiphyseal chondrocytes serially cultured in monolayer. Connect Tissue Res. 2002;43:56-62.
35. Schnabel M, Marlovits S, Eckhoff G, et al. Dedifferentiationassociated changes in morphology and gene expression in primary human articular chondrocytes in cell culture. Osteoarthritis Cartilage. 2002;10:62-70.
36. Benya PD, Shaffer JD. Dedifferentiated chondrocytes reexpress the differentiated collagen phenotype when cultured in agarose gels. Cell. 1982;30:215-224.
37. Bonaventure J. Kadhom N. Cohen-Solal L, et al. Reexpression of cartilage-specific genes by dedifferentiated human articular chondrocytes cultured in alginate beads. Exp Cell Res. 1994;212:97-104.
38. Grande DA. Mason J. Light E, et al. Stem cells as platforms for delivery of genes to enhance cartilage repair. J Bone Joint Surg Am. 2003;85-A(suppl 2): 111-116.
39. Trippel S. Growth factor actions on articular cartilage. J Rheumatol. 1995;22:129-131.
40. DeLise AM. Fischer L. Tuan RS. Cellular interactions and signaling in cartilage development. Osteoarthritis Cartilage. 2000;8:309-334.
41. Martinek V, Ueblacker P, Imhoff AB. Current concepts of gene therapy and cartilage repair. J Bone Joint Surg Br. 2003;85:782-788.
42. Palmer G, Pascher A, Gouze E, et al. Development of gene-based therapies for cartilage repair. Crit Rev Eukaryot Gene Expr. 2002; 12:259-273.
43. Trippel SB, Ghivizzani SC, Nixon AJ. Gene-based approaches for the repair of articular cartilage. Gene Ther. 2004;11:351-359.
44. Fujisato T, Sajiki T, Liu Q, et al. Effect of basic fibroblast growth factor on cartilage regeneration in chondrocyte-seeded collagen sponge scaffold. Biomaterials. 1996;17:155-162.
45. Hunziker EB, Rosenberg L. Induction of repair in partial thickness articular cartilage lesions by timed release of TGF-beta. Trans Orthop Res Soc. 1994;19:236.
46. Humbel RE. Hormonal Proteins and Peptides. New York: Academic Press; 1984:57-79.
47. Tsukaaki T, Usa T, Matsumoto T, et al. Effect of transforming growth factor-beta on the insulin-like growth factor-I autocrine/paracrine axis in culture rat articular chondrocytes. Exp Cell Res. 1994;215:9-16.
48. Auw Yank KG, Saris DBF, Verbout AJ. The effect of synovial fluid from injured knee joints on in vitro chondrogenesis. Tissue Eng. 2006;12:1-8.
49. Dell'Accio F, DeBari C, Luyten FP. Microenvironment and phenotypic stability specify tissue formation by human articular cartilage-derived cells in vivo. Exp Cell Res. 2003;287:16-27.
50. Dell'Accio F, Vanlauwe J, Bellemans J, et al. Expanded phenotypically stable chondrocytes persist in the repair tissue and contribute to cartilage matrix formation and structural integration in a goat model of autologous chondrocyte implantation. J Orthop Res. 2003;21:123-131.
51. Saris D, Vanlauwe J, Victor J. Characterized chondrocyte implantation results in better structural repair when treating symptomatic cartilage defects of the knee in a randomized controlled trial versus microfracture. Am J Sports Med. 2008;36:235-246.
52. Dell'Accio F, DeBari C, Luyten FP. Molecular markers predictive of the capacity of expanded human articular chondrocytes to form stable cartilage in vivo. Arthritis Rheum. 2001;44:1608-1619.
53. O'Driscoll SW, Marx RG, Fitzsimmons JS, et al. Method for automated cartilage histomorphometry. Tissue Eng. 1999;5:13-23.
54. Solchaga LA, Tognana E, Penick K, et al. A rapid seeding technique for the assembly of large cell/scaffold composite constructs. Tissue Eng. 2006;12:1851-1863.
55. Dar A, Shachar M, Leor J, et al. Optimization of cardiac cell seeding and distribution in 3D porous alginate scaffolds. Biolechnol Bioeng. 2002;80:305.
56. Saini S, Wick TM. Concentric cylinder bioreactor for production of tissue engineered cartilage: effect of seeding density and hydrodynamic loading on construct development. Biolechnol Prog. 2003;19:510.
57. Merchuk JC. Shear effects on suspended cells. Adv Biochem Eng Biolechnol. 1991;44:65.
58. Anseth KS, Metters AT, Bryant SJ, et al. In situ forming degradable networks and their application in tissue engineering and drug delivery. J Control Release. 2002;78:199-209.
59. Hoffman AS. Hydrogels for biomedical applications. Ann N Y Acad Sci. 2001;944:62-73.
60. Sharma B, Elisseeff JH. Engineering structurally organized cartilage and bone tissues. Ann Biomed Eng. 2004;32:148-159.
61. Elisseeff J, Puleo C, Yang F, et al. Advances in skeletal tissue engineering with hydrogels. Orthod Craniofac Res. 2005;8:150-161.
62. Vinatier C, Guicheux J, Daculsi G, et al. Cartilage and bone tissue engineering using hydrogels. Biomed Mater Eng. 2006; 16(4 suppl): S107-S113.
63. Silverman R, Passaretti D, Huang W, et al. Injectable tissueengineered cartilage using a fibrin glue polymer. Plast Reconstr Surg. 1999;103:1809-1818.
64. Bouhadir KH, Lee KY, Alsberg E, et al. Degradation of partially oxidized alginate and its potential application for tissue engineering. Biotechnol Prog. 2001;17:945-950.
65. Rowley JA, Madlambayan G, Mooney DJ. Alginate hydrogels as synthetic extracellular matrix materials. Biomaterials. 1999;20:45-53.
66. Elisseeff J, Anseth K, Sims D. Transdermal photopolymerization of poly(ethylene oxide)-based injectable hydrogels for tissue engineered cartilage. Plast Reconstr Surg. 1999;104:1014-1022.
67. Elisseeff J, Mcintosh W, Anseth K. Photoencapsulation of chondrocytes in poly (ethylene oxide)-based semi-interpenetrating networks. J Biomed Mate Res. 2000;51:164-171.
68. Williams CG, Kim TK, Taboas A, et al. In vitro chondrogenesis of bone marrow-derived mesenchymal stem cells in a photopolymerizing hydrogel. Tissue Eng. 2003;9:679-688.
69. Mann BK, Schmedlen RH, West JL. Tethered-TGF-beta increases extracellular matrix production of vascular smooth muscle cells. Biomaterials. 2001;22:439-444.
70. Mahn BK, Tsai AT, Scott-Burden T. Modification of surfaces with cell adhesion peptides alters extracellular matrix deposition. Biomaterials. 1999;20:2281-2286.
71. Hern DL, Hubbell JA. Incorporation of adhesion peptides into nonadhesive hydrogels useful for tissue resurfacing. J Biomed Mater Res. 1998;39:266-276.
72. Burdick JA, Anseth KS. Photoencapsulation of osteoblasts in injectable RGD-modified PEG hydrogels for bone tissue engineering. Biomaterials. 2002;23:4315-4323.
73. Elisseeff J, Mcintosh W, Fu K, et al. Controlled-release of IGF-I and TGF-beta 1 in a photopolymerizing hydrogel for cartilage tissue engineering. J Orthop Res. 2001;19:1098-1104.
74. Kim TK, Sharma B, Williams CG, et al. Experimental model for cartilage tissue engineering to regenerate the zonal organization of articular cartilage. Osteoarthritis Cartilage. 2003;11:653-664.
75. Saha K, Pollock J, Schaffer D, et al. Designing synthetic materials to control stem cell phenotype. Curr Opin Chem Biol. 2007;11:1-7.
76. Steinberg MS. Mechanism of tissue reconstruction by dissociated cells. II. Time-course of events. Science. 1962;137:762-763.
77. Yang S, Leong KF, Du Z, et al. The design of scaffolds for use in tissue engineering. Part II. Rapid prototyping techniques. Tissue Eng. 2002;8:1-11.
78. Landers R, Hübner U, Schmelzeisen R, et al. Rapid prototyping of scaffolds derived from thermoreversible hydrogels and tailored for applications in tissue engineering. Biomaterials. 2002;23:4437-4447.
79. Mironov V, Boland T, Trusk T, et al. Organ printing: computeraided jet-based 3D tissue engineering. Trends Biotechnol. 2003;21:157-161.
80. Forgacs G, Foty RA, Shafrir Y. Viscoelastic properties of living embryonic tissues: a quantitative study. Biophys J. 1998;74:2227-2234.
81. Beysens DA, Forgacs G, Glazier JA. Cell sorting is analogous to phase separation in fluids. Proc Natl Acad Sci USA. 2000;97:9467-9471.
82. Gutowska A, Jeong B, Jasionowski M. Injectable gels for tissue engineering. Anat Rec. 2001;263:342-349.
83. Boland T, Mironov V, Gutowska A, et al. Cell and organ printing 2: fusion of cell aggregates in three-dimensional gels. Anat Rec A Discov Mol Cell Evol Biol. 2003;272:497-502.
84. Atala A. Wake Forest Institute for Regenerative Medicine. http://www.wfirm.org/. Accessed December 28, 2007.
85. McHale MK, Setton LA, Chilkoti A. Synthesis and in vitro evaluation of enzymatically cross-linked elastin-like polypeptide gels for cartilaginous tissue repair. Tissue Eng. 2005;11:1768-1779.
86. Urry DW, Parker TM, Reid MC, et al. Biocompatibility of the bioelastic materials, poly (GVGVP) and its gamma-irradiation cross-linked matrix: summary of generic biological test results. J Bioact Compat Polym. 1991;6:263-282.
87. Urry DW, Pattanaik A, Xu J, et al. Elastic protein-based polymers in soft tissue augmentation and generation. J Biomater Sci Polym Ed. 1998;9:1015-1048.
88. Betre H, Setton LA, Meyer DE, et al. Characterization of a genetically engineered elastin-like polypeptide for cartilaginous tissue repair. Biomacromolecules. 2002;3:910-916.
89. Betre H. Ong SR. Guilak F. et al. Chondrocylic differentiation of human adipose-derived adult stem cells in elastin-like polypeptide. Biomaterials. 2006;27:91-99.
90. Erickson GR, Gimble JM. Franklin DM, et al. Chondrogenic potential of adipose tissue-derived stromal cells in vitro and in vivo. Biochem Biophys Res Commun. 2002;290:763-769.
91. Zuk PA, Zhu M, Mizuno H, et al. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue Eng. 2001;7:211-228.
92. Guilak F, Lott KE, Awad HA, et al. Clonal analysis of the differentiation potential of human adipose-derived adult stem cells. J Cell Physiol. 2006;206:229-237.
93. Moutsatsos IK, Turgeman G, Zhou S, et al. Exogenously regulated stem cell-mediated gene therapy for bone regeneration. Mol Ther. 2001;3:449-461.
94. Hasharoni A, Zilberman Y, Turgeman G, et al. Murine spinal fusion induced by engineered mesenchymal stem cells that conditionally express bone morphogenic protein-2. J Neurosurg: Spine. 2005;3:47-52.
95. Kimelman N, Pelled G, Helm GA, et al. Review: gene and stem cell based therapeutics for bone regeneration and repair. Tissue Eng. 2007;13:1135-1150.
96. Hamm A, Krott N, Breibach I, et al. Efficient transfection method for primary cells. Tissue Eng. 2002;8:235-245.
97. Orlowski S, Mir LM. Cell electropermeabilization: a new tool for biochemical and pharmacological studies. Bioehim Biophys Acta. 1993;1154:51-63.
98. Gehl J. Electroporation: theory and methods, perspectives for drug delivery, gene therapy and research. Acta Physiol Stand. 2003;177:437-447.
99. Asian H, Zilberman Y, Arbeli V, et al. Nucleofection-based ex vivo nonviral gene delivery to human stem cells as a platform for tissue regeneration. Tissue Eng. 2006;12:877-889.
100. Gafni Y, Turgeman G, Liebergal M, et al. Stem cells as vehicles for orthopedic gene therapy. Gene Ther. 2004;11:417-426.
101. Adkisson HD, Gillis MP, Davis EC, et al. In vitro generation of scaffold independent neocartilage. Clin Orlhop Relat Res. 2001; 391S:S280-S294.
102. Toole BP, Banerjee S, Turner R, et al. Hyaluronan-cell interactions in limb development. In: Hinchliffe JR, Hurle JM, Summerbell D, eds. Developmental Patterning of the Vertebrate Limb. New York: Plenum Press; 1992:215-223.
103. Toole BP. Hyaluronan in morphogenesis. J Intern Med. 1997;242:35-40.
104. Vacanti CA, Kim W, Schloo B, ct al. Joint resurfacing with cartilage grown in situ from cell-polymer structures. Am J Sports Med. 1994;22:485-488.
105. Kujawa MJ, Caplan AT. Hyaluronic acid bonded to cell culture surfaces stimulates chondrogenesis in stage 24 limb mesenchyme cultures. Dev Biol. 1986;114:504-518.
106. Kujawa MJ, Carrino DA, Caplan Al. Substrate-bonded hyaluronic acid exhibits a size-dependent stimulation of chondrogenic differentiation of stage 24 limb mesenchymal cells in culture. Dev Biol. 1985;114:519-528.
107. West DC, Hampson IN, Arnold F, et al. Angiogenesis induced by degradation products of hyaluronic acid. Science. 1985;228:1324-1326.
108. West DC, Wennar S. The effect of hyaluronate and its oligosaccharides on endothelial cell proliferation and monolayer integrity. Exp Cell Res. 1989;183:179-196.
109. Solchaga LA, Yoo JU, Lundberg M, et al. Hyaluronan-based polymers in the treatment of osteochondral defects. J Orthop Res. 2000;18:773-780.
110. Caplan AI. Design parameters for functional tissue engineering. In: Guilak F, ed. Functional Tissue Engineering. New York: Springer; 2003:129-128.
111. Solchaga LA, Goldberg VM, Caplan AI. Cartilage regeneration using principles of tissue engineering. Clin Orthop Relat Res. 2001;391S:S161-S170.
112. From Hyaluronic Acid to HYAFF. Available at: http://www.fidiapharma. com/files/index.cfm?id-rst = 112. Accessed: January 5, 2007.
113. Campoccia D, Doherty P, Radice M. Semisynthetic resorbable materials from hyaluronan esterification. Biomaterials. 1998; 19:2101-2127.
114. Solchaga LA, Gao J, Dennis JE, et al. Treatment of osteochondral defects with autologous bone marrow in a hyaluronan-based delivery vehicle. Tissue Eng. 2002;8:333-347.
115. Solchaga LA, Dennis JE, Goldberg VM, et al. Hyaluronic acidbased polymers as cell carriers for tissue-engineered repair of bone and cartilage. J Orthop Res. 1999;17:205-213.
116. Solchaga LA, Temenoff JS, Gao J, et al. Repair of osteochondral defects with hyaluronan- and polyester-based scaffolds. Osteoarthritis Cartilage. 2005;13:297-309.